0.42
price up icon3.73%   0.0151
after-market Handel nachbörslich: .40 -0.02 -4.76%
loading
Schlusskurs vom Vortag:
$0.4049
Offen:
$0.3965
24-Stunden-Volumen:
771.51K
Relative Volume:
0.06
Marktkapitalisierung:
$46.38M
Einnahmen:
$20.27M
Nettoeinkommen (Verlust:
$-63.80M
KGV:
-0.2763
EPS:
-1.52
Netto-Cashflow:
$-68.35M
1W Leistung:
+3.19%
1M Leistung:
+110.00%
6M Leistung:
-4.57%
1J Leistung:
-70.83%
1-Tages-Spanne:
Value
$0.386
$0.42
1-Wochen-Bereich:
Value
$0.369
$0.4399
52-Wochen-Spanne:
Value
$0.1417
$1.42

Carisma Therapeutics Inc Stock (CARM) Company Profile

Name
Firmenname
Carisma Therapeutics Inc
Name
Telefon
(267) 491-6422
Name
Adresse
3675 MARKET STREET, PHILADELPHIA
Name
Mitarbeiter
46
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
CARM's Discussions on Twitter

Vergleichen Sie CARM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CARM
Carisma Therapeutics Inc
0.42 46.38M 20.27M -63.80M -68.35M -1.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-12 Herabstufung Robert W. Baird Outperform → Neutral
2024-12-10 Herabstufung BTIG Research Buy → Neutral
2024-04-11 Eingeleitet BTIG Research Buy
2023-10-03 Eingeleitet CapitalOne Overweight
2023-07-06 Eingeleitet Evercore ISI Outperform
2023-05-31 Hochstufung Jefferies Hold → Buy
2023-05-24 Eingeleitet H.C. Wainwright Buy
2023-04-14 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Carisma Therapeutics Inc Aktie (CARM) Neueste Nachrichten

pulisher
Jun 15, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Stock Position Decreased by Millennium Management LLC - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Takes Position in Marker Therapeutics, Inc. (NASDAQ:MRKR) - Defense World

Jun 15, 2025
pulisher
Jun 12, 2025

Carisma Therapeutics Secures Nasdaq Listing Approval - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

Is the 250% Carisma Therapeutics Stock (CARM) Surge a Sucker’s Rally? - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

Carisma Therapeutics Stock (CARM) Retreats 35% After a Massive Rally - TipRanks

Jun 11, 2025
pulisher
Jun 10, 2025

US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews

Jun 10, 2025
pulisher
Jun 10, 2025

Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 10, 2025
pulisher
Jun 05, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 05, 2025
pulisher
Jun 02, 2025

Carisma Therapeutics Reports Q1 2025 Financial Results - TipRanks

Jun 02, 2025
pulisher
May 24, 2025

Carisma Therapeutics Inc (CARM): An Important Analyst Insights - Stocksregister

May 24, 2025
pulisher
May 22, 2025

Layoff Tracker: Eikon Cuts Workforce by 15%, Citing ‘External Forces’ - BioSpace

May 22, 2025
pulisher
May 20, 2025

Carisma Therapeutics Inc (NASDAQ: CARM) Stock Sentiment: What’s Wall Street Saying? - Stocksregister

May 20, 2025
pulisher
May 14, 2025

Carisma Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Pre-market Movers: LUCY, ALUR, PLRZ, AXDX... - RTTNews

May 14, 2025
pulisher
May 08, 2025

Financial Metrics Unveiled: Carisma Therapeutics Inc (CARM)’s Key Ratios in the Spotlight - DWinneX

May 08, 2025
pulisher
May 05, 2025

Carisma Therapeutics Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
Apr 24, 2025

Caribou cuts 32% of staff, further purges pipeline to focus on 2 oncology CAR-T prospects - Fierce Biotech

Apr 24, 2025
pulisher
Apr 23, 2025

Carisma Therapeutics to Present at Upcoming Conferences - Seeking Alpha

Apr 23, 2025
pulisher
Apr 22, 2025

Biopharma restructurings reflect strategy of short-term pain for long-term gains - BioWorld MedTech

Apr 22, 2025
pulisher
Apr 16, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Given Average Rating of “Hold” by Analysts - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Sagimet Biosciences (NASDAQ:SGMT) and Carisma Therapeutics (NASDAQ:CARM) Head-To-Head Review - Defense World

Apr 15, 2025
pulisher
Apr 08, 2025

Philly weekly roundup: Carisma Therapeutics layoffs; PPA's AI ticketing; HiveBio's first cohort - Technical.ly

Apr 08, 2025
pulisher
Apr 07, 2025

Carisma Therapeutics Inc’s Market Journey: Closing Weak at 0.19, Down -0.26 - DWinneX

Apr 07, 2025
pulisher
Apr 06, 2025

CARISMA THERAPEUTICS Earnings Preview: Recent $CARM Insider Trading, Hedge Fund Activity, and More - Nasdaq

Apr 06, 2025
pulisher
Apr 03, 2025

Carisma Therapeutics Focuses on Strategic Alternatives Amid Revised Operating Plan - MSN

Apr 03, 2025
pulisher
Apr 02, 2025

Philly’s Carisma Therapeutics slashed its workforce to 6 from 46 for sale or wind down - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

Carisma Therapeutics (NASDAQ:CARM) Price Target Lowered to $1.00 at D. Boral Capital - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Carisma Therapeutics to Present at AASLD 2024 on Liver Fibrosis Treatment - MSN

Apr 01, 2025
pulisher
Apr 01, 2025

Carisma winds down operations, lays off 95% of remaining staff - Fierce Biotech

Apr 01, 2025
pulisher
Mar 31, 2025

Penn spinout Carisma Therapeutics lays off 84% of its staff, explores possible sale - The Business Journals

Mar 31, 2025
pulisher
Mar 31, 2025

Carisma Therapeutics Provides Corporate Updates - Citizen Tribune

Mar 31, 2025
pulisher
Mar 31, 2025

Carisma Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Carisma Therapeutics Board Approves Revised Operating Plan; Reduces Workforce - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

Carisma Therapeutics Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Carisma Therapeutics Explores Sale Options as Company Halts R&D Programs - Stock Titan

Mar 31, 2025
pulisher
Mar 29, 2025

Carisma Therapeutics (CARM) to Release Earnings on Monday - The AM Reporter

Mar 29, 2025
pulisher
Mar 28, 2025

Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Business And Shares Still Trailing The Industry - simplywall.st

Mar 28, 2025
pulisher
Mar 26, 2025

The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors - Business Wire

Mar 26, 2025
pulisher
Mar 22, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives Consensus Rating of “Hold” from Analysts - Defense World

Mar 22, 2025

Finanzdaten der Carisma Therapeutics Inc-Aktie (CARM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):